Cargando…
Proteomics: Progress and Promise of High-Throughput Proteomics in Chronic Kidney Disease
Current proteomic tools permit the high-throughput analysis of the blood proteome in large cohorts, including those enriched for chronic kidney disease (CKD) or its risk factors. To date, these studies have identified numerous proteins associated with cross-sectional measures of kidney function, as...
Autores principales: | Schlosser, Pascal, Grams, Morgan E., Rhee, Eugene P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326701/ https://www.ncbi.nlm.nih.gov/pubmed/37076045 http://dx.doi.org/10.1016/j.mcpro.2023.100550 |
Ejemplares similares
-
Integrated proteomic and metabolomic modules identified as biomarkers of mortality in the Atherosclerosis Risk in Communities study and the African American Study of Kidney Disease and Hypertension
por: Zhou, Linda, et al.
Publicado: (2022) -
Transcriptome- and proteome-wide association studies nominate determinants of kidney function and damage
por: Schlosser, Pascal, et al.
Publicado: (2023) -
Circulating Proteins and Mortality in CKD: A Proteomics Study of the AASK and ARIC Cohorts
por: Srialluri, Nityasree, et al.
Publicado: (2023) -
The Promise of Proteomics for the Study of ADP-Ribosylation
por: Daniels, Casey M., et al.
Publicado: (2015) -
Can sacubitril/valsartan become the promising drug to delay the progression of chronic kidney disease?
por: CHEN, Yang, et al.
Publicado: (2020)